TGF-β signaling in tumor suppression and cancer progression
The DOI matches its Crossref record; 325 of the 325 references it cites were found in a registry or an index.
Abstract
Epithelial and hematopoietic cells have a high turnover and their progenitor cells divide continuously, making them prime targets for genetic and epigenetic changes that lead to cell transformation and tumorigenesis. The consequent changes in cell behavior and responsiveness result not only from genetic alterations such as activation of oncogenes or inactivation of tumor suppressor genes, but also from altered production of, or responsiveness to, stimulatory or inhibitory growth and differentiation factors. Among these, transforming growth factor beta (TGF-beta) and its signaling effectors act as key determinants of carcinoma cell behavior. The autocrine and paracrine effects of TGF-beta on tumor cells and the tumor micro-environment exert both positive and negative influences on cancer development. Accordingly, the TGF-beta signaling pathway has been considered as both a tumor suppressor pathway and a promoter of tumor progression and invasion. Here we evaluate the role of TGF-beta in tumor development and attempt to reconcile the positive and negative effects of TGF-beta in carcinogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As previously mentioned in this review, TGF-β itself and its family members have been recognized to be involved in cancer development [81], and TGF-β possesses a pro-oncogenic role in MPM connected to immune suppression [82,83].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [81]
Citations
Cites
Items 201–325 of 325
Sehgal, I., & Thompson, T. C. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.2.407 · Cited by 166
Seon, B. K., Matsuno, F., Haruta, Y., Kondo, M., & Barcos, M. P. (1997) · PubMed · Cited by 166
Yanagisawa, K., Osada, H., Masuda, A., Kondo, M., Saito, T., Yatabe, Y., Takagi, K., Takahashi, T., & Takahashi, T. (1998) · Oncogene · doi:10.1038/sj.onc.1202052 · Cited by 165
Atfi, A., Buisine, M., Mazars, A., & Gespach, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24731 · Cited by 162 · cited 1×
“Increased levels of Smad3 or Smad4 can induce apoptosi”
BackgroundTGF-β singaling and cancer: structural and functional consequences of mutations in Smads
Hata, A., Massagué, J., & Shi, Y. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01247-7 · Cited by 161
Karumanchi, S. A., Knebelmann, B., Grüning, W., Dhanabal, M., Walz, G., Stillman, I. E., & Sukhatme, V. P. (1999) · PubMed · Cited by 159
Sirard, C., Kim, S., Mirtsos, C., Tadich, P., Hoodless, P. A., Itié, A., Maxson, R., Wrana, J. L., & Mak, T. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.2063 · Cited by 159
Vertebrate mesendoderm induction and patterning
Kimelman, D., & Griffin, K. J. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00095-2 · Cited by 158 · cited 1×
“, TGF-βs are involved in epithelial to mesenchymal transdifferentiation, and related family members serve the same function in mesoderm inductio”
BackgroundChoi, M. E., & Ballermann, B. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.21144 · Cited by 156
Feng, X.-H., Filvaroff, E. H., & Derynck, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24237 · Cited by 155
Self-citationSaito, H., Tsujitani, S., Oka, S., Kondo, A., Ikeguchi, M., Maeta, M., & Kaibara, N. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991015)86:8<1455::aid-cncr11>3.0.co;2-l · Cited by 154
Kim, R. H., Wang, D., Tsang, M., Martin, J., Huff, C., de Caestecker, M. P., Parks, W. T., Meng, X., Lechleider, R. J., Wang, T., et al. (2000) · PubMed · Cited by 152
Hua, X., Miller, Z. A., Wu, G., Shi, Y., & Lodish, H. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13130 · Cited by 152
Kang, H.-Y., Lin, H.-K., Hu, Y.-C., Yeh, S., Huang, K.-E., & Chang, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061305498 · Cited by 152
Chen, T., Carter, D., Garrigue‐Antar, L., & Reiss, M. (1998) · PubMed · Cited by 150
Pardali, E., Xie, X.-Q., Tsapogas, P., Itoh, S., Arvanitidis, K., Heldin, C.-H., ten Dijke, P., Grundström, T., & Sideras, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3552 · Cited by 150
Reddy, K. B., Krueger, J. S., B. Kondapaka, S., & Diglio, C. A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990719)82:2<268::aid-ijc18>3.0.co;2-4 · Cited by 149
Calonge, M. J., & Massagué, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33637 · Cited by 146
FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle
Aghdasi, B., Ye, K., Resnick, A., Huang, A., Ha, H. C., Guo, X., Dawson, T. M., Dawson, V. L., & Snyder, S. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041614198 · Cited by 146
Lee, D. K., Park, S. H., Yi, Y., Choi, S.-G., Lee, C., Parks, W. T., Cho, H., de Caestecker, M. P., Shaul, Y., Roberts, A. B., et al. (2001) · Genes & Development · doi:10.1101/gad.856201 · Cited by 143 · cited 1×
“, whereas the hepatitis B virus–encoded nuclear pX protein enhances Smad-mediated transcription in response to TGF-&beta”
BackgroundUeki, N., Nakazato, M., Ohkawa, T., Ikeda, T., Amuro, Y., Hada, T., & Higashino, K. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(92)90201-l · Cited by 142
Knaus, P. I., Lindemann, D., DeCoteau, J. F., Perlman, R., Yankelev, H., Hille, M., Kadin, M. E., & Lodish, H. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3480 · Cited by 140
Arteaga, C. L., Dugger, T. C., Moses, H. L., Hurd, S. D., & Pietenpol, J. A. (1993) · PubMed · Cited by 139
Wallick, S. C., Figari, I. S., Morris, R. E., Levinson, A. D., & Palladino, M. A. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.6.1777 · Cited by 138
Yahata, T., de Caestecker, M. P., Lechleider, R. J., Andriole, S., Roberts, A. B., Isselbacher, K. J., & Shioda, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8825 · Cited by 138 · cited 1×
“Besides the interaction of the Smad complex with CBP/p300, Smad4 can also engage another coactivator, named MSG1, into the transcription complex to enhance the Smad respons”
BackgroundShioda, T., Lechleider, R. J., Dunwoodie, S. L., Li, H., Yahata, T., de Caestecker, M. P., Fenner, M. H., Roberts, A. B., & Isselbacher, K. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9785 · Cited by 137
Identification of STRAP, a Novel WD Domain Protein in Transforming Growth Factor-β Signaling
Datta, P. K., Chytil, A., Gorska, A. E., & Moses, H. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34671 · Cited by 136 · cited 1×
“, and STRAP interacts with both TβRII and TβRI to decrease TGF-β signalin”
BackgroundWang, X.-J., Liefer, K. M., Tsai, S., O’Malley, B. W., & Roop, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8483 · Cited by 135
Smad7 mediates apoptosis induced by transforming growth factor β in prostatic carcinoma cells
Landström, M., Heldin, N., Bu, S., Hermansson, A., Itoh, S., ten Dijke, P., & Heldin, C. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00470-x · Cited by 133
Ständer, M., Naumann, U., Dumitrescu, L., Heneka, M. T., Löschmann, P.-A., Gulbins, E., DICHGANS, J., & Weller, M. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300709 · Cited by 132
Iavarone, A., & Massagué, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.916 · Cited by 132
Ishisaki, A., Yamato, K., Nakao, A., Nonaka, K., Ohguchi, M., ten Dijke, P., & Nishihara, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24293 · Cited by 131
Zhang, Y., & Derynck, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001526200 · Cited by 131
Self-citationA novel Smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-β signal transduction
Kim, R. H., Wang, D., Tsang, M., Martin, J., Huff, C., de Caestecker, M. P., Parks, W. T., Meng, X., Lechleider, R. J., Wang, T., et al. (2000) · Genes & Development · doi:10.1101/gad.14.13.1605 · Cited by 131
Alexandrow, M. G., Kawabata, M., Aakre, M., & Moses, H. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3239 · Cited by 130
Guo, Y., Jacobs, S. C., & Kyprianou, N. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970516)71:4<573::aid-ijc11>3.0.co;2-d · Cited by 130
Schiemann, W. P., Pfeifer, W. M., Levi, E., Kadin, M. E., & Lodish, H. F. (1999) · Blood · doi:10.1182/blood.v94.8.2854.420k07_2854_2861 · Cited by 128
Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
Inge, T. H., Hoover, S. K., Süßkind, B., Barrett, S. K., & Bear, H. D. (1992) · PubMed · Cited by 127
Griswold-Prenner, I., Kamibayashi, C., Maruoka, E. M., Mumby, M. C., & Derynck, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6595 · Cited by 127 · cited 1×
“29 ), the Bα subunit of the protein phosphatase 2A interacts with type I receptor”
BackgroundSelf-citationWieser, R., Attisano, L., Wrana, J. L., & Massagué, J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7239 · Cited by 127
Geiser, A. G., Kim, S. J., Roberts, A. B., & Sporn, M. B. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.84 · Cited by 126
Wong, M. P., Cheung, N., Yuen, S. T., Leung, S. Y., & Chung, L. P. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990611)81:6<851::aid-ijc2>3.0.co;2-d · Cited by 125
Choy, L., & Derynck, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31455 · Cited by 125
Self-citationTanaka, S., & Wands, J. R. (1996) · PubMed · Cited by 122
Wang, D., Kanuma, T., Mizunuma, H., Takama, F., Ibuki, Y., Wake, N., Mogi, A., Shitara, Y., & Takenoshita, S. (2000) · PubMed · Cited by 121
Lee, B. I., Park, S. H., Kim, J. W., Sausville, E. A., Kim, H. T., Nakanishi, O., Trepel, J. B., & Kim, S. J. (2001) · PubMed · Cited by 120
Reiss, M. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00251-8 · Cited by 118
Stearns, M. E., Garcia, F. U., Fudge, K., Rhim, J. S., & Wang, M. (1999) · PubMed · Cited by 116
Epithelioid sarcoma: a clinicopathologic and prognostic study of 26 cases.
Evans, H. L., & Baer, S. C. (1993) · PubMed · Cited by 115
Chipuk, J. E., Bhat, M. B., Hsing, A. Y., Ma, J., & Danielpour, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100913200 · Cited by 115
Bandyopadhyay, A. M., Zhu, Y., Cibull, M. L., Bao, L., Chen, C., & Sun, L. (1999) · PubMed · Cited by 115
Buchmann, A., Ruggeri, B., Klein–Szanto, A. J., & Balmain, A. (1991) · PubMed · Cited by 114
Self-citationQing, J., Zhang, Y., & Derynck, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004731200 · Cited by 110
Self-citationThe immunoregulatory effects of NK cells: the role of TGF-β and implications for autoimmunity
Horwitz, D. A., Gray, J. D., Ohtsuka, K., Hirokawa, M., & Takahashi, T. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01149-3 · Cited by 110 · cited 1×
“Increased expression of TGF-β1 by tumor cells decreased NK cell activit”
BackgroundM6P/IGF2R is mutated in squamous cell carcinoma of the lung
Kong, F., Anscher, M. S., Washington, M. K., Killian, J. K., & Jirtle, R. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203437 · Cited by 108
Himelstein, B. P., Lee, E. J., Sato, H., Seiki, M., & Muschel, R. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201012 · Cited by 107
Smad7 inhibits the survival nuclear factor κB and potentiates apoptosis in epithelial cells
Lallemand, F., Mazars, A., Prunier, C., Bertrand, F., Kornprost, M., Gallea, S., Roman‐Roman, S., Cherqui, G., & Atfi, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204167 · Cited by 106
Caulı́n, C., Scholl, F. G., Frontelo, P., Gamallo, C., & Quintanilla, M. (1995) · PubMed · Cited by 105
Duivenvoorden, W., Hirte, H. W., & Singh, G. K. J. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1026404227624 · Cited by 101
N-acetyl transferase 2 genotypes, meat intake and breast cancer risk
Gertig, D. M., Hankinson, S. E., Hough, H., Spiegelman, D., Colditz, G. A., Willett, W. C., Kelsey, K. T., & Hunter, D. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990105)80:1<13::aid-ijc3>3.0.co;2-w · Cited by 101
RhoB Is Stabilized by Transforming Growth Factor β and Antagonizes Transcriptional Activation
Engel, M. E., Datta, P. K., & Moses, H. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9921 · Cited by 101
Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.
Chen, T., Triplett, J., Dehner, B., Hurst, B. M., Colligan, B. M., Pemberton, J. O., Graff, J. R., & Carter, J. H. (2001) · PubMed · Cited by 101
Marzo, A. L., Fitzpatrick, D. R., Robinson, B. W. S., & Scott, B. (1997) · UWA Profiles and Research Repository (University of Western Australia) · Cited by 100
Chung, Y., Song, J., Lee, J. Y., Jung, Y. T., Seo, E., Choi, S. W., & Rhyu, M. (1996) · PubMed · Cited by 100
Jirtle, R. L., Hankins, G. R., Reisenbichler, H., & Boyer, I. J. (1994) · Carcinogenesis · doi:10.1093/carcin/15.8.1473 · Cited by 99
Saltzman, A. G., Munro, R., Searfoss, G. H., Franks, C. F., Jaye, M., & Ivashchenko, Y. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4096 · Cited by 98
Ito, N., Kawata, S., Tamura, S., Shirai, Y., Kiso, S., Tsushima, H., & Matsuzawa, Y. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)90156-6 · Cited by 96
Lu, S., Zhang, W. C., Akiyama, Y., Nomizu, T., & Yuasa, Y. (1996) · PubMed · Cited by 95
Gajdusek, C. M., Luo, Z., & Mayberg, M. R. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041570118 · Cited by 94
Activation of caspase-8 in transforming growth factor-β-induced apoptosis of human hepatoma cells
Shima, Y., Nakao, K., Nakashima, T., Kawakami, A., Nakata, K., Hamasaki, K., Kato, Y., Eguchi, K., & Ishii, N. (1999) · Hepatology · doi:10.1002/hep.510300503 · Cited by 94
Altered Regulation of TGF‐β1 and TGF‐α in Primary Keratinocytes and Papillomas Expressing v‐Ha‐ras
Glick, A. B., Sporn, M. B., & Yuspa, S. H. (1991) · Molecular Carcinogenesis · doi:10.1002/mc.2940040308 · Cited by 93 · cited 1×
“Because Ras signaling also induces the expression of urokinase and the consequent generation of plasmi”
BackgroundDpc4 transcriptional activation and dysfunction in cancer cells.
Dai, J. L., Turnacioglu, K. K., Schutte, M. E. M., Sugar, A. Y., & Kern, S. E. (1998) · PubMed · Cited by 90
Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4
Morén, A., Itoh, S., Moustakas, A., ten Dijke, P., & Heldin, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203798 · Cited by 90
Transforming growth factor-? responsiveness inDPC4/SMAD4-null cancer cells
Dai, J. L., Schutte, M., Bansal, R. K., Wilentz, R. E., Sugar, A. Y., & Kern, S. E. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199909)26:1<37::aid-mc5>3.0.co;2-6 · Cited by 88
Hagedorn, H., Bachmeier, B., & Nerlich, A. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.4.669 · Cited by 87
Patil, S., Wildey, G. M., Brown, T. L., Choy, L., Derynck, R., & Howe, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004861200 · Cited by 87
Self-citationDai, J. L., Bansal, R. K., & Kern, S. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1427 · Cited by 86
Stoler, A., Stenback, F., & Balmain, A. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.5.1103 · Cited by 86
Self-citationTang, B., de Castro, K. J. D., Barnes, H. E., Parks, W. T., Stewart, L. V., Böttinger, E. P., Danielpour, D., & Wakefield, L. M. (1999) · PubMed · Cited by 84
Ma, D., & Niederkorn, J. Y. (1995) · PubMed Central · Cited by 84
Thompson, A., Kerr, D., & Steel, C. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.140 · Cited by 83
Somatic alterations of the SMAD-2 gene in human colorectal cancers
Takagi, Y., Koumura, H., Futamura, M., Aoki, S., Ymaguchi, K., Kida, H., Tanemura, H., Shimokawa, K., & Saji, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.645 · Cited by 83
Involvement of caspase family proteases in transforming growth factor-beta-induced apoptosis.
Rh, C., & Chang, T. (1997) · PubMed · Cited by 82
Microsatellite instability and mutated type II transforming growth factor-β receptor gene in gliomas
Izumoto, S., Arita, N., Ohnishi, T., Hiraga, S., Taki, T., Tomita, N., Ohue, M., & Hayakawa, T. (1997) · Cancer Letters · doi:10.1016/s0304-3835(96)04583-1 · Cited by 81
Go, C., Li, P., & Wang, X. (1999) · PubMed · Cited by 79
Chaouchi, N., Arvanitakis, L., Auffredou, M., Blanchard, D. A., Vázquez, A., & Sharma, S. (1995) · PubMed · Cited by 79
Junker, U., Knöfel, B., Nuske, K., Rebstock, K., Steiner, T., Wunderlich, H., Junker, K., & Reinhold, D. (1996) · Cytokine · doi:10.1006/cyto.1996.0105 · Cited by 77
Iglesias, M., Frontelo, P., Gamallo, C., & Quintanilla, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203764 · Cited by 76
Won, J., Kim, H., Park, E. J., Hong, Y., Kim, S., & Yun, Y. (1999) · PubMed · Cited by 76
Arteaga, C. L., Koli, K. M., Dugger, T. C., & Clarke, R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.1.46 · Cited by 75
Effects of transforming growth factor β on growth of human mammary epithelial cells in culture
Hosobuchi, M., & Stampfer, M. R. (1989) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02623723 · Cited by 73
Kordula, T., Gütgemann, I., Rose‐John, S., Roeb, E., Osthues, A., Tschesche, H., Koj, A., Heinrich, P. C., & Graeve, L. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81431-k · Cited by 71
Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
Fink, S. P., Swinler, S. E., Lutterbaugh, J., Massagué, J., Thiagalingam, S., Kinzler, K. W., Vogelstein, B., Willson, J. K. V., & Markowitz, S. D. (2001) · PubMed · Cited by 71
Elo, J. P., Akinola, L. A., Poutanen, M., Vihko, P., Kyllönen, A. P., Lukkarinen, O., & Vihko, R. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960328)66:1<37::aid-ijc7>3.0.co;2-# · Cited by 69
Expression of the c-ski proto-oncogene in human melanoma cell lines
Fumagalli, S., Doneda, L., Nomura, N., & Larizza, L. (1993) · Melanoma Research · doi:10.1097/00008390-199304000-00004 · Cited by 66 · cited 1×
“For example, elevated expression of the proto-oncogene c-Ski in melanom”
BackgroundImmunosuppressive Factors: Role in Cancer Development and Progression
Botti, C., Seregni, E. C., Ferrari, L., Martinetti, A., & Bombardieri, E. (1998) · The International Journal of Biological Markers · doi:10.1177/172460089801300201 · Cited by 63
Goto, D., Yagi, K., Inoue, H., Iwamoto, I., Kawabata, M., Miyazono, K., & Kato, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00658-9 · Cited by 61
FKBP12 Is a Negative Regulator of Transforming Growth Factor-β Receptor Internalization
Yao, D., Doré, J. J. E., & Leof, E. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.13149 · Cited by 61
Wojtowicz-Praga, S., Verma, U. M., Wakefield, L., Esteban, J. M., Hartmann, D., & Mazumder, A. (1996) · Journal of Immunotherapy · doi:10.1097/00002371-199605000-00001 · Cited by 60 · cited 1×
“For example, the combination of anti-TGF-β antibodies with IL-2–reduced tumor formation in a highly metastatic melanoma cell line, which was unaffected by either treatment alon”
BackgroundVincent-Hubert, F., Hagiwara, K., Yang, K., Stoner, G. D., Demetrick, D. J., & Bennett, W. P. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0934 · Cited by 57
Kawate, S., Takenoshita, S., Ohwada, S., Mogi, A., Fukusato, T., Makita, F., Kuwano, H., & Morishita, Y. (1999) · International Journal of Oncology · doi:10.3892/ijo.14.1.127 · Cited by 56
Park, J. A., Wang, E., Kurt, R. A., Schluter, S. F., Hersh, E. M., & Akporiaye, E. T. (1997) · PubMed · Cited by 56
Weinberg, W. C., Brown, P. D. N., Stetler‐Stevenson, W. G., & Yuspa, S. H. (1990) · Differentiation · doi:10.1111/j.1432-0436.1990.tb00470.x · Cited by 53
Shimizu, S., Nishikawa, Y., Kuroda, K., Takagi, S., Kozaki, K., Hyuga, S., Saga, S., & Matsuyama, M. (1996) · PubMed · Cited by 51
Chang, E., & Goldberg, H. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4473 · Cited by 51
Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas
Takagi, S., Kinouchi, Y., Hiwatashi, N., Chida, M., Nagashima, F., Takahashi, S., Negoro, K., Shimosegawa, T., & Toyota, T. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991015)86:8<1431::aid-cncr7>3.0.co;2-r · Cited by 47
Evidence That Smad2 Is a Tumor Suppressor Implicated in the Control of Cellular Invasion
Prunier, C., Mazars, A., Noë, V., Bruyneel, E., Mareel, M., Gespach, C., & Atfi, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.22919 · Cited by 47
Tomita, S., Deguchi, S., Miyaguni, T., Muto, Y., Tamamoto, T., & Toda, T. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006167210269 · Cited by 47
Ohue, M., Tomita, N., Monden, T., Miyoshi, Y., Ohnishi, T., Izawa, H., Kawabata, Y., Sasaki, M., Sekimoto, M., Nishisho, I., et al. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961009)68:2<203::aid-ijc11>3.0.co;2-b · Cited by 47
Amoroso, S., Huang, N., Roberts, A. B., Potter, M., & Letterio, J. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.189 · Cited by 46
Venkatasubbarao, K., Ahmed, M. M., Mohiuddin, M., Swiderski, C. F., Lee, E., Gower, W. R., Salhab, K. F., McGrath, P. C., Strodel, W. E., & Freeman, J. W. (2000) · PubMed · Cited by 45
Owen, R. D., & Ostrowski, M. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3866 · Cited by 45
Kitagawa, K., Murata, A., Matsuura, N., Tohya, K., Takaichi, S., Monden, M., & Inoue, M. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960328)66:1<91::aid-ijc16>3.0.co;2-e · Cited by 37
Koli, K. M., Ramsey, T. T., Ko, Y., Dugger, T. C., Brattain, M. G., & Arteaga, C. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8296 · Cited by 35
Mechanism for Mutational Inactivation of the Tumor Suppressor Smad2
Prunier, C., Ferrand, N., Frottier, B., Pessah, M., & Atfi, A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3302-3313.2001 · Cited by 35
Péron, P., Rahmani, M., Zagar, Y., Durand-Schneider, A.-M., Lardeux, B., & Bernuau, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005919200 · Cited by 34 · cited 1×
“, suggesting that there is transcriptional cooperation of Smads with the AP-1 complex and a dependence of these TGF-β responses on Ras/MAP kinase and/or phosphatidylinositol-3-OH kinase (PI-3-K) signalin”
BackgroundTurco, A., Coppa, A., Aloe, S., Baccheschi, G., Morrone, S., Zupi, G., & Colletta, G. (1999) · International Journal of Cancer · Cited by 33
Somatic alterations of the DPC4 and Madr2 genes in colorectal cancers and relationship to metastasis
Ohtaki, N., Yamaguchi, A., Goi, T., Fukaya, T., Takeuchi, K., Katayama, K., Hirose, K., & Urano, T. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.2.265 · Cited by 32
Fafeur, V., O'Hara, B., & Böhlen, P. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.2.135 · Cited by 30
Santibáñez, J. F., Frontelo, P., Iglesias, M., Martínez, J., & Quintanilla, M. (1999) · PubMed · doi:10.1002/(sici)1097-4644(19990701)74:1<61::aid-jcb7>3.0.co · Cited by 29
Adam, A. J. M., Felcher, A. H., Woods, M. L., Pulaski, B. A., Hutter, E. K., Frelinger, J. G., & Lord, E. M. (1994) · Journal of Immunotherapy · doi:10.1097/00002371-199404000-00001 · Cited by 26
Yamanaka, R., Tanaka, R., Yoshida, S., Saitoh, T., Fujita, K., & Naganuma, H. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006289901702 · Cited by 22
Kim, T., Mo, E. K., Yoo, C., Lee, C.-T., Han, S., Shim, Y.-S., & Kim, Y. W. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00169-0 · Cited by 16
MHC-dependent cytolysis of autologous tumor cells by lymphocytes infiltrating urothelial carcinomas
Housseau, F., Zeliszewski, D., Roy, M., Paradis, V., Richon, S., Ricour, A., Bougaran, J., Prapotnich, D., Vallancien, G., Benoît, G., et al. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970516)71:4<556::aid-ijc9>3.0.co;2-t · Cited by 15
Research works printed but not linked: 2
- Caulin, C., Scholl, S.G., Frontelo, P., Gamallo, C. & Quintanilla, M. Chronic exposure of cultured transfected mouse epidermal cells to TGFβ1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Diff. 6, 1027–1035 (1995).
- Dickson, R.B. et al. Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β-estradiol or v-Ha-ras oncogene. Proc. Natl Acad. Sci. USA 84, 837–841 (1987). · DOI · Paper page
Cited by
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Causes and consequences of microRNA dysregulation in cancer
Croce, C. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2634 · Cited by 2,998
TGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804
Self-citation
Metadata
- Authors
- Derynck, R., Akhurst, R. J., & Balmain, A.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Derynck, Rik
- Venue
- Nature Genetics
- Published
- 2001-10-01
- Volume
- 29
- Issue
- 2
- Pages
- 117-129
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1565561072
- Cited by
- 2,275
- References
- 319
- Citations by year
- 2026: 21 · 2025: 32 · 2024: 38 · 2023: 59 · 2022: 52 · 2021: 75 · 2020: 71 · 2019: 74 · 2018: 87 · 2017: 87 · 2016: 74 · 2015: 107 · 2014: 120 · 2013: 89 · 2012: 115
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Update notices
- erratum (2001-11-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- www.springer.com/tdm (unspecified)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- March of Dimes Foundation
- American Heart Association
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- TGF-beta signaling, tumor suppression, tumor progression, carcinogenesis, tumor microenvironment, autocrine and paracrine signaling, tumor invasion, epithelial cells, hematopoietic cells, tumor suppressor, oncogenes
- MeSH terms
- Animals, Humans, Neoplasms, Signal Transduction, Transforming Growth Factor beta, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.